DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,418 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,221,913 | -12.5% | 48,917 | -12.5% | 0.87% | -14.5% |
Q1 2024 | $13,963,843 | +7.4% | 55,918 | -0.5% | 1.02% | +0.3% |
Q4 2023 | $13,003,853 | -7.0% | 56,211 | -0.2% | 1.02% | -24.1% |
Q3 2023 | $13,979,444 | +115.3% | 56,346 | +108.2% | 1.34% | +44.8% |
Q2 2023 | $6,493,680 | -5.6% | 27,057 | -0.9% | 0.93% | -7.9% |
Q1 2023 | $6,882,204 | -6.2% | 27,306 | -1.2% | 1.01% | -6.0% |
Q4 2022 | $7,339,128 | +3.7% | 27,651 | +0.9% | 1.07% | -7.4% |
Q3 2022 | $7,078,000 | +1.4% | 27,404 | -0.5% | 1.16% | +8.3% |
Q2 2022 | $6,981,000 | -14.7% | 27,535 | -1.3% | 1.07% | -2.5% |
Q1 2022 | $8,185,000 | -16.0% | 27,904 | -5.8% | 1.09% | -12.6% |
Q4 2021 | $9,742,000 | +5.9% | 29,609 | -2.0% | 1.25% | -2.0% |
Q3 2021 | $9,201,000 | +9.2% | 30,224 | -3.7% | 1.28% | +10.4% |
Q2 2021 | $8,425,000 | +17.0% | 31,393 | -1.8% | 1.16% | +11.9% |
Q1 2021 | $7,199,000 | -2.0% | 31,983 | -3.3% | 1.04% | -7.3% |
Q4 2020 | $7,345,000 | +1.2% | 33,066 | -1.9% | 1.12% | -7.5% |
Q3 2020 | $7,260,000 | +19.3% | 33,717 | -2.0% | 1.21% | +11.3% |
Q2 2020 | $6,085,000 | +22.8% | 34,416 | -3.9% | 1.08% | +7.1% |
Q1 2020 | $4,957,000 | -16.8% | 35,814 | -7.8% | 1.01% | +8.0% |
Q4 2019 | $5,959,000 | +3.3% | 38,829 | -2.8% | 0.94% | -7.1% |
Q3 2019 | $5,770,000 | -3.6% | 39,947 | -4.6% | 1.01% | -5.7% |
Q2 2019 | $5,984,000 | +6.0% | 41,871 | -2.1% | 1.07% | +4.2% |
Q1 2019 | $5,646,000 | +26.8% | 42,765 | -0.9% | 1.03% | +43.0% |
Q4 2018 | $4,451,000 | -9.0% | 43,163 | -4.2% | 0.72% | -9.1% |
Q3 2018 | $4,893,000 | +4.0% | 45,034 | -5.6% | 0.79% | -6.1% |
Q2 2018 | $4,705,000 | -17.2% | 47,682 | -17.8% | 0.84% | -9.5% |
Q1 2018 | $5,683,000 | +3.5% | 58,041 | -1.9% | 0.93% | +7.5% |
Q4 2017 | $5,492,000 | +7.2% | 59,173 | -0.9% | 0.86% | +5.6% |
Q3 2017 | $5,123,000 | +1.2% | 59,721 | -0.4% | 0.82% | -0.6% |
Q2 2017 | $5,062,000 | -2.7% | 59,977 | -1.4% | 0.82% | -4.5% |
Q1 2017 | $5,200,000 | +7.8% | 60,799 | -1.9% | 0.86% | +4.0% |
Q4 2016 | $4,825,000 | -3.0% | 61,996 | -2.3% | 0.83% | -4.2% |
Q3 2016 | $4,973,000 | -22.8% | 63,443 | -0.5% | 0.87% | -23.0% |
Q2 2016 | $6,438,000 | +3.8% | 63,743 | -2.5% | 1.12% | +3.1% |
Q1 2016 | $6,200,000 | -3.5% | 65,358 | -5.5% | 1.09% | -5.1% |
Q4 2015 | $6,423,000 | +6.0% | 69,150 | -2.7% | 1.15% | +1.6% |
Q3 2015 | $6,058,000 | -12.0% | 71,094 | -11.6% | 1.13% | +0.6% |
Q2 2015 | $6,885,000 | -0.9% | 80,440 | -1.7% | 1.12% | +1.4% |
Q1 2015 | $6,946,000 | -2.3% | 81,817 | -1.4% | 1.11% | -0.5% |
Q4 2014 | $7,109,000 | +11.2% | 82,949 | -1.4% | 1.11% | +8.6% |
Q3 2014 | $6,394,000 | -9.2% | 84,150 | -5.9% | 1.03% | -3.9% |
Q2 2014 | $7,043,000 | -7.0% | 89,459 | -11.4% | 1.07% | -2.8% |
Q1 2014 | $7,570,000 | -4.6% | 100,941 | -1.8% | 1.10% | -3.3% |
Q4 2013 | $7,932,000 | +3.7% | 102,740 | -6.9% | 1.14% | -0.4% |
Q3 2013 | $7,648,000 | +6.7% | 110,342 | -2.6% | 1.14% | +5.9% |
Q2 2013 | $7,167,000 | – | 113,230 | – | 1.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |